Skip to contentE
Endovia Health Sciences, Inc.
E
EDVAEndovia Health Sciences, Inc. Q4 2016 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$280.52K$280.52Kderived+1.2% vs Q4 2015 Net Income-$37.22K-$37.22KderivedN/M vs Q4 2015 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$149,066−9.3% Operating Incomederived-$37,330N/M Operating Cash Flowderived$4,857−65.5% Free Cash Flowderived-$10,373N/M Margins · derivedGross margin53.1%−6.1 pt vs Q4 2015
Operating margin-13.3%−32.9 pt vs Q4 2015
Net margin-13.3%−32.9 pt vs Q4 2015
ended Dec 31, 2016 · filed Mar 28, 2017 · 87 d after period end